EWTX Insider Transactions
182 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
EWTX insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Donovan Joanne M. | CMO | 2026-08-13 | Sale | 2,919.00 | $43.4065 |
| Russell Alan J | Chief Scientific Officer | 2026-08-12 | Sale | 390.00 | $44.46 |
| Russell Alan J | Chief Scientific Officer | 2026-08-12 | Sale | 2,273.00 | $43.6759 |
| Russell Alan J | Chief Scientific Officer | 2026-08-12 | Sale | 3,238.00 | $43.6775 |
| Derakhshan Behrad | Chief Business Officer | 2026-08-12 | Sale | 2,475.00 | $43.6984 |
| Derakhshan Behrad | Chief Business Officer | 2026-08-12 | Sale | 150.00 | $44.4433 |
| Derakhshan Behrad | Chief Business Officer | 2026-08-12 | Sale | 304.00 | $44.5018 |
| Derakhshan Behrad | Chief Business Officer | 2026-08-12 | Sale | 2,171.00 | $43.7934 |
| Donovan Joanne M. | CMO | 2026-08-12 | Sale | 800.00 | $44.5175 |
| Donovan Joanne M. | CMO | 2026-08-12 | Sale | 104.00 | $44.4253 |
| Donovan Joanne M. | CMO | 2026-08-12 | Sale | 2,779.00 | $43.7073 |
| Donovan Joanne M. | CMO | 2026-08-12 | Sale | 2,839.00 | $43.784 |
| MOORE JOHN R | General Counsel | 2026-08-12 | Sale | 2,419.00 | $43.7985 |
| MOORE JOHN R | General Counsel | 2026-08-12 | Sale | 99.00 | $44.5019 |
| MOORE JOHN R | General Counsel | 2026-08-12 | Sale | 59.00 | $44.4142 |
| MOORE JOHN R | General Counsel | 2026-08-12 | Sale | 2,439.00 | $43.8081 |
| KOCH KEVIN | President and CEO | 2026-08-12 | Sale | 913.00 | $44.33 |
| KOCH KEVIN | President and CEO | 2026-08-12 | Sale | 8,276.00 | $43.6582 |
| KOCH KEVIN | President and CEO | 2026-08-12 | Sale | 8,782.00 | $43.6408 |
| Russell Alan J | Chief Scientific Officer | 2026-07-01 | Sale | 69,648.00 | $39.4089 |
| Russell Alan J | Chief Scientific Officer | 2026-07-01 | Sale | 130,352.00 | $39.406 |
| Donovan Joanne M. | CMO | 2026-05-05 | Sale | 50,000.0 | $38.57 |
| Donovan Joanne M. | CMO | 2026-05-04 | Sale | 5,230.0 | $31.29 |
| Donovan Joanne M. | CMO | 2026-04-01 | Sale | 28,662.0 | $32.31 |
| Donovan Joanne M. | CMO | 2026-03-31 | Sale | 21,338.0 | $32.12 |
| Donovan Joanne M. | CMO | 2026-03-27 | Sale | 6,735.0 | $30.98 |
| Donovan Joanne M. | CMO | 2026-03-27 | Sale | 9,623.0 | $30.98 |
| Edris Badreddin | Director | 2026-01-21 | Sale | 66,477.0 | $29.44 |
| Edris Badreddin | Director | 2026-01-21 | Sale | 10,463.0 | $29.44 |
| Edris Badreddin | Director | 2026-01-21 | Sale | 7,605.0 | $29.44 |
| Edris Badreddin | Director | 2026-01-21 | Sale | 17,236.0 | $29.44 |
| Edris Badreddin | Director | 2026-01-21 | Sale | 13,690.0 | $29.44 |
| Russell Alan J | Chief Scientific Officer | 2025-11-12 | Sale | 100,000.0 | $21.12 |
| Fox Jonathan C | Director | 2025-11-11 | Purchase | 10,700.0 | $18.64 |
| Russell Alan J | Chief Scientific Officer | 2025-08-26 | Sale | 100,000.0 | $14.6 |
| MOORE JOHN R | General Counsel | 2025-08-12 | Sale | 2,098.0 | $13.39 |
| Derakhshan Behrad | Chief Business Officer | 2025-08-12 | Sale | 2,491.0 | $13.39 |
| Carruthers R Michael | Chief Financial Officer | 2025-08-12 | Sale | 1,428.0 | $13.39 |
| Russell Alan J | Chief Scientific Officer | 2025-08-12 | Sale | 1,907.0 | $13.39 |
| KOCH KEVIN | President and CEO | 2025-08-12 | Sale | 7,972.0 | $13.39 |
| Donovan Joanne M. | CMO | 2025-08-12 | Sale | 2,862.0 | $13.39 |
| Russell Alan J | Chief Scientific Officer | 2025-05-02 | Sale | 1,551.0 | $16.45 |
| MOORE JOHN R | General Counsel | 2025-05-02 | Sale | 1,930.0 | $16.45 |
| KOCH KEVIN | President and CEO | 2025-05-02 | Sale | 4,276.0 | $16.45 |
| Donovan Joanne M. | CMO | 2025-05-02 | Sale | 5,187.0 | $16.45 |
| Derakhshan Behrad | Chief Business Officer | 2025-05-02 | Sale | 1,691.0 | $16.45 |
| Carruthers R Michael | Chief Financial Officer | 2025-05-02 | Sale | 1,314.0 | $16.45 |
| Thompson Peter A. | Director,TenPercentOwner | 2025-04-03 | Purchase | 124,193.0 | $20.13 |
| Thompson Peter A. | Director,TenPercentOwner | 2025-04-03 | Purchase | 372,578.0 | $20.13 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2025-04-03 | Purchase | 124,193.0 | $20.13 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2025-04-03 | Purchase | 124,193.0 | $20.13 |
| OrbiMed Genesis GP LLC | Director,TenPercentOwner | 2025-04-03 | Purchase | 124,193.0 | $20.13 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2025-04-03 | Purchase | 372,578.0 | $20.13 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2025-04-03 | Purchase | 372,578.0 | $20.13 |
| OrbiMed Genesis GP LLC | Director,TenPercentOwner | 2025-04-03 | Purchase | 372,578.0 | $20.13 |
| Russell Alan J | Chief Scientific Officer | 2025-03-07 | Sale | 200.0 | $30.02 |
| KOCH KEVIN | President and CEO | 2025-03-07 | Sale | 100.0 | $30.0 |
| Russell Alan J | Chief Scientific Officer | 2025-02-06 | Sale | 1,200.0 | $30.13 |
| KOCH KEVIN | President and CEO | 2025-02-06 | Sale | 900.0 | $31.13 |
| Russell Alan J | Chief Scientific Officer | 2025-02-05 | Sale | 8,015.0 | $30.02 |
| KOCH KEVIN | President and CEO | 2025-02-05 | Sale | 8,636.0 | $30.03 |
| Derakhshan Behrad | Chief Business Officer | 2025-02-05 | Sale | 10,000.0 | $30.03 |
| Donovan Joanne M. | CMO | 2025-01-28 | Sale | 25,000.0 | $27.63 |
| Russell Alan J | Chief Scientific Officer | 2024-12-30 | Sale | 100,000.0 | $27.37 |
| Semigran Marc | Chief Development Officer | 2024-12-24 | Sale | 1,729.0 | $30.08 |
| Semigran Marc | Chief Development Officer | 2024-12-24 | Sale | 27,980.0 | $29.66 |
| MOORE JOHN R | General Counsel | 2024-09-23 | Sale | 20,922.0 | $27.63 |
| Russell Alan J | Chief Scientific Officer | 2024-09-20 | Sale | 815.0 | $29.51 |
| Russell Alan J | Chief Scientific Officer | 2024-09-20 | Sale | 74,185.0 | $28.25 |
| MOORE JOHN R | General Counsel | 2024-09-20 | Sale | 50,000.0 | $28.37 |
| Donovan Joanne M. | CMO | 2024-09-20 | Sale | 7,162.0 | $28.29 |
| Derakhshan Behrad | Chief Business Officer | 2024-09-20 | Sale | 42,068.0 | $29.03 |
| Carruthers R Michael | Chief Financial Officer | 2024-09-20 | Sale | 50,000.0 | $28.55 |
| Carruthers R Michael | Chief Financial Officer | 2024-09-20 | Sale | 24,960.0 | $28.59 |
| Carruthers R Michael | Chief Financial Officer | 2024-09-20 | Sale | 4,064.0 | $28.59 |
| Carruthers R Michael | Chief Financial Officer | 2024-09-20 | Sale | 46,068.0 | $28.59 |
| MOORE JOHN R | General Counsel | 2024-05-02 | Sale | 1,956.0 | $18.91 |
| Carruthers R Michael | Chief Financial Officer | 2024-05-02 | Sale | 2,157.0 | $18.91 |
| Derakhshan Behrad | Chief Business Officer | 2024-05-02 | Sale | 1,718.0 | $18.91 |
| Russell Alan J | Chief Scientific Officer | 2024-05-02 | Sale | 1,576.0 | $18.91 |
| Donovan Joanne M. | CMO | 2024-05-02 | Sale | 3,682.0 | $18.91 |
| KOCH KEVIN | President and CEO | 2024-05-02 | Sale | 3,152.0 | $18.91 |
| MOORE JOHN R | General Counsel | 2024-02-09 | Sale | 8,029.0 | $20.01 |
| Derakhshan Behrad | Chief Business Officer | 2024-02-09 | Sale | 4,800.0 | $20.04 |
| MOORE JOHN R | General Counsel | 2024-02-08 | Sale | 3,813.0 | $20.01 |
| Derakhshan Behrad | Chief Business Officer | 2024-02-08 | Sale | 4,600.0 | $20.01 |
| MOORE JOHN R | General Counsel | 2024-02-07 | Sale | 17,993.0 | $20.0 |
| Derakhshan Behrad | Chief Business Officer | 2024-02-07 | Sale | 600.0 | $20.0 |
| Carruthers R Michael | Chief Financial Officer | 2024-01-23 | Sale | 90,000.0 | $15.78 |
| Thompson Peter A. | Director,TenPercentOwner | 2024-01-23 | Purchase | 454,545.0 | $11.0 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2024-01-23 | Purchase | 454,545.0 | $11.0 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2024-01-23 | Purchase | 454,545.0 | $11.0 |
| OrbiMed Genesis GP LLC | Director,TenPercentOwner | 2024-01-23 | Purchase | 454,545.0 | $11.0 |
| MOORE JOHN R | General Counsel | 2023-12-27 | Sale | 8,497.0 | $10.5 |
| Fox Jonathan C | Director | 2023-12-26 | Purchase | 10,857.0 | $9.3 |
| Russell Alan J | Chief Scientific Officer | 2023-12-26 | Sale | 172,585.0 | $9.33 |
| Derakhshan Behrad | Chief Business Officer | 2023-05-02 | Sale | 1,747.0 | $8.9 |
| MOORE JOHN R | General Counsel | 2023-05-02 | Sale | 1,897.0 | $8.9 |
| Carruthers R Michael | Chief Financial Officer | 2023-05-02 | Sale | 1,336.0 | $8.9 |
| Russell Alan J | Chief Scientific Officer | 2023-05-02 | Sale | 1,602.0 | $8.9 |